Sheila M. Grant
Directeur Technique/Scientifique/R&D chez XENON PHARMACEUTICALS INC.
Postes actifs de Sheila M. Grant
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| XENON PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | 01/08/2020 | - |
Historique de carrière de Sheila M. Grant
Anciens postes connus de Sheila M. Grant
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CORREVIO PHARMA CORP. | Directeur des opérations | 01/03/2013 | 27/05/2020 |
| Corporate Officer/Principal | 01/08/2003 | 01/03/2013 | |
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Corporate Officer/Principal | - | - |
Formation de Sheila M. Grant
| University of Essex | Undergraduate Degree |
| Simon Fraser University | Masters Business Admin |
| London School of Hygiene & Tropical Medicine | Graduate Degree |
Statistiques
Internationale
| Canada | 5 |
| Royaume-Uni | 3 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| XENON PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
Twinstrand Therapeutics, Inc.
Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Health Technology |
- Bourse
- Insiders
- Sheila M. Grant
- Expérience
